After more than two years of talks, hopes are high of completing an accord by November 15, though the heart of the document—how to share pathogens and vaccines—is set to be worked out later.
This year's headlines on COVID-19 featured new research on COVID-related mortality, post-acute sequelae of infection, vaccine safety, and potential therapeutics.
Recent Comments